Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc.（DNTH）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
dnth · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$145
Consensus
$112
+37.5% upside
Low
$55.00
Median: $120 · Last Close: $81.36
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$111.91
37.5% upside
High Target
$145
78.2%
Low Target
$55
-32.4%
Current Price
$81.36
as of today
Based on analyst price targets, the DNTH stock price prediction for the next 12 months ranges from $55 to $145. The consensus DNTH price forecast of $111.91 implies 37.5% upside from the current price of $81.36.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $78.95 | ↓ 2.96% |
1-day model range: $78.5–$79.4. Peak: $79.4 (-2.96%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $122 | +50.1% |
| 2028 | $159 | +95.1% |
| 2029 | $187 | +130.3% |
| 2030 | $208 | +155.2% |
| 2031 | — | +171.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DNTH · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-12 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-10 | Clear Street | Maintains | Buy→Buy |
| 2026-03-10 | Baird | Maintains | Outperform→Outperform |
| 2026-03-10 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-10 | Raymond James | Upgrade ↑ | Outperform→Strong Buy |
| 2026-03-09 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-03-09 | Truist Securities | Maintains | Buy→Buy |
| 2026-03-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Dianthus Therapeutics, Inc. (DNTH) stock. Of the recent 40 rating actions, 1 were upgrades and 0 were downgrades. 10 analysts currently cover DNTH.
分析师推荐趋势
DNTH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 92.5% YoY
Revenue Next Year
$2M
↑ 41.3% YoY
EPS This Year
$-3.68
EPS Next Year
$-4.45
↑ 20.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast DNTH EPS of $-3.68 for the current fiscal year, based on estimates from 9 analysts. The DNTH revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DNTH 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。DNTH 的共识目标价为 $111.91（+37.5% 上行空间），分析师共识为 Buy。
DNTH 的短期预测（明日）为 $78.95（-2.96%）。 DNTH 对 2027 年的股价预测均值为 $122。 DNTH 对 2030 年的预测区间为 $195–$221。
Dianthus Therapeutics, Inc. 在 NASDAQ 上市，代码 DNTH。DNTH 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
DNTH 预测 · 8 个问题根据 10 位华尔街分析师，DNTH 的 12 个月平均目标价为 $111.91，最高 $145.00、最低 $55.00。若有图表，中位目标价可在上方查看。相对当前价 $81.36，隐含约 +37.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.